Monday, January 19, 2015

10 Best Sliver Stocks To Own For 2014

Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.

What: Shares of Ascena Retail Group (NASDAQ: ASNA  ) were down as much as 11% today after the clothing retailer posted disappointing results in its third-quarter earnings report. ��

So what: The parent of Lane Bryant and other brands said that net income dropped 37%, to $31.2 million, or $0.26 a share, after adjustments. Analysts had expected an EPS of $0.31. The drop in profits came in spite of a 46% increase in revenue to $1.14 billion, due to last year's acquisitions of the Lane Bryant and Catherines brand. Still,a same-store sales decline of 4% was evidence of the weakness in the quarter. Ascena also lowered its full-year forecast, saying it now expects EPS for the year at $1.10-$1.20, against former projections of $1.20-$1.30. The analyst consensus had been at $1.26.

Now what: It's hard to put a silver lining on this report, as it was pretty much an all-around stinker, with an earnings miss, same-store sales decline, and a guidance cut. CEO David Jaffe said that bad weather and poor merchandise choices at Lane Bryant and dressbarn hurt the company during the quarter, but that sales have improved so far in the current period, as Ascena seems to have to put those mistakes behind it. The current quarter's report should let investors know if these problems are a continuing trend, or just one bad quarter.

Top 5 Companies To Buy Right Now: Uranerz Energy Corp (URZ)

Uranerz Energy Corporation (Uranerz), incorporated on May 26, 1999, is a uranium company focused on commercial in-situ recovery (ISR) uranium production. The Company is principally focused on the development of its properties in the Powder River Basin area into commercial ISR uranium mines. The Company operates in two segments: Arkose Mining Venture (Arkose) and the Company�� remaining operations. Its Wyoming properties, all in the Powder River Basin, totaling 87,414 acres include 100% owned properties, totaled 25,261 acres as of December 31, 2011, and properties of Arkose Mining Venture, in which it held an 81% interest, totaling 62,153 acres as of December 31, 2011. As of December 31, 2011, a total of 380 drill holes were completed on Powder River Basin properties, representing approximately 288,404 feet of drilling at an average depth of 755 feet per hole. The Arkose Mining Venture properties consist of unpatented mineral lode claims, state leases and fee (private) mineral leases.

As of December 31, 2011, the Company�� Powder River Basin properties include both its 100% owned properties and those properties included within the Arkose Mining Venture. These principal properties comprise in total approximately 87,414 acres and consist of a combination of federal mining claims, state mineral leases and private fee mineral leases. Its 100% owned properties in the Powder River Basin include Jane Dough, Collins Draw, North Rolling Pin, Hank, Nichols Ranch, Willow Creek, West North-Butte, East Nichols and North Nichols.

The Company had interests in several projects that lie within the Powder River Basin but outside of the project areas. These properties include the Verna Ann, Niles Ranch, Reno Creek, and South Reno Creek projects which cover approximately 1,694 acres. Within the Nichols Ranch Unit, Uranerz had 36 unpatented lode mining claims, two fee surface and mineral leases and one surface use agreement. Within the Hank Unit, it had 66 unpatented lode mining claims, two fe! e surface and mineral leases and one surface use agreement. The Hank Unit permit boundary encompasses approximately 2,250 acres.

The West North-Butte property covers approximately 1,960 acres of land and consists of 125 unpatented lode mining claims and one surface use agreement. The east portion of the West North-Butte property covers approximately 325 acres of land and is consists of 17 unpatented lode mining claims and one surface use agreement. The Willow Creek property covers approximately 220 acres of land and is consists of 11 unpatented lode mining claims and one surface use agreement.

The Arkose Mining Venture properties consist of unpatented lode mining claims, fee mineral leases, and state mineral leases. The land surface consists of private, federal and state lands. There are 2,641 unpatented lode mining claims included in the Arkose Property, which comprise 43,207 acres and 65 fee mineral leases and three state leases included in the Arkose Property which comprise 18,946 acres.

Advisors' Opinion:
  • [By John Udovich]

    Since the start of the week, small cap nuclear fuel stock USEC Inc (NYSE: USU) more than doubled for investors, something that has not happened for investors in uranium stocks like Uranium Resources, Inc (NASDAQ: URRE), Denison Mines Corp (NYSEMKT: DNN), Ur-Energy Inc. (NYSEMKT: URG) and Uranerz Energy Corp (NYSEMKT: URZ). To recap: USEC Inc closed at the $6 level on Friday, but then it surged to the $15 level on Monday only to open at the $10 level on Tuesday when it ultimately closed at $12.46. So what in the world is going on with USEC Inc and is it time to revisit nuclear fuel and uranium stocks?

10 Best Sliver Stocks To Own For 2014: Triple-S Management Corporation (GTS)

Triple-S Management Corporation, through its subsidiaries, offers a portfolio of managed care and related products in the commercial and Medicare markets in Puerto Rico. The company operates in three segments: Managed Care, Life Insurance, and Property and Casualty Insurance. It provides managed care products, including health maintenance organization plans; preferred provider organization plans; Medicare Supplement products; Medicare Advantage products; Medicaid plans; and Medicare Part D, a prescription drug plan; and claims processing and other administrative services. The company offers its managed care products to employers, professional and trade associations, individuals, and government entities. It also provides various life, accident, disability, and health and annuity insurance products to individuals; and property and casualty insurance products, which include commercial multi-peril, commercial property mono-line, auto physical damage, auto liability, and dwelli ng policies to commercial customers. The company markets its products through a network of internal sales force, direct mail, independent brokers and agents, telemarketing staff, and the Internet. Triple-S Management Corporation was incorporated in 1997 and is based in San Juan, Puerto Rico.

Advisors' Opinion:
  • [By Brian Pacampara]

    What: Shares of Puerto Rican managed-care company Triple-S Management (NYSE: GTS  ) popped 11% today after its quarterly results topped Wall Street expectations.

10 Best Sliver Stocks To Own For 2014: RealNetworks Inc.(RNWK)

RealNetworks, Inc. provides network-delivered digital media products and services to manage, play, and share digital media in the United States, Europe, and internationally. It develops and markets software products and services that enable the creation, distribution, and consumption of digital media, including audio and video. The company?s Core Products segment develops and provides software as a service (SaaS) services, including ring-back tone, music-on-demand, video-on-demand, and messaging services for mobile carriers; and e-commerce services, such as business intelligence, subscriber management, and billing for carrier customers. It also licenses Helix server software that allows companies and institutions to broadcast live and on-demand audio, video, and other multimedia programming to users over the Internet. In addition, this segment provides professional and systems integration services; and SuperPass, a subscription service, which provides consumers with acces s to a range of digital entertainment content. Its Emerging Products segment offers RealPlayer, a media player software, which include features and services that enable consumers to discover, play, download, manage, and edit digital video. The company?s Games segment is involved in developing, publishing, licensing, and distributing casual games, such as board, card, puzzle, word, and hidden-object games for PC?s, social networks, mobile handsets, and smartphones through digital download, online subscription play, third-party portals, social networks, and mobile devices. It distributes games principally in North America, Europe, and Latin America through the company?s own Websites, which are operated under the GameHouse, Zylom, and Atrativa brands, and through Websites owned or managed by third parties. RealNetworks, Inc. was founded in 1994 and is headquartered in Seattle, Washington.

Advisors' Opinion:
  • [By Carol Hymowitz]

    CEOs who aren�� comfortable around technology and digital trends will have difficulty setting strategy for the future, said Dawn Lepore, former CEO of Drugstore.com and a director at AOL Inc., TJX Cos. (TJX) and RealNetworks Inc. (RNWK)

10 Best Sliver Stocks To Own For 2014: PowerShares DWA Energy Momentum Portfolio (PXI)

PowerShares Dynamic Energy Sector Portfolio (the Fund) seeks investment results that correspond generally to the price and yield of an equity index called the Dynamic Energy Sector Intellidex Index (the Index). The Index consists of stocks of 60 United States energy companies. These are companies that are principally engaged in the business of producing, distributing or servicing energy-related products, including oil and gas exploration and production, refining, oil services, pipeline, and solar, wind and other non-oil-based energy. Stocks are selected principally on the basis of their capital appreciation potential as identified by the AMEX (the Intellidex Provider) pursuant to an Intellidex methodology. The Fund�� investment adviser is PowerShares Capital Management LLC.

The Fund, using an indexing investment approach, attempts to replicate the performance of the Index. The Fund generally will invest in all of the stocks comprising the Index in proportion to their weightings in the Index. The Fund will normally invest at least 80% of its total assets in common stocks of energy companies. The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index.

Advisors' Opinion:
  • [By Todd Shriber, ETF Professor]

    Unusual volume (at least 5X ADV): QuantShares US Market Neutral Anti-Beta ETF (NYSE: BTAL), iShares 10+ Year Credit Bond ETF (NYSE: CLY), iShares Morningstar Small Value ETF (NYSE: JKL) and the PowerShares Dynamic Energy ETF (NYSE: PXI).

10 Best Sliver Stocks To Own For 2014: Insys Therapeutics Inc (INSY)

Insys Therapeutics, Inc., incorporated on June 15, 1990, is a pharmaceutical company that develops and seeks to commercialize pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The Company�� pharmaceuticals portfolio consists of one approved product and a number of product candidates targeting cancer-supportive care and cancer therapy. The Company�� product candidate includes Subsys, Dronabinol SG Capsule, Dronabinol RT Capsule, Dronabinol Oral Solution, Dronabinol Inhalation Device, and Dronabinol IV Solution. The Company is also developing cancer therapeutics, which is LEP-ETU, a formulation of paclitaxel, the active ingredient in the cancer drugs Taxol and Abraxane. On August 19, 2011, the Food & Drug Administration (FDA) approved its Dronabinol SG Capsule product, a generic equivalent to Marinol, for the treatment of chemotherapy induced nausea and vomiting (CINV), and anorexia associated with weight loss in patients with acquired immune deficiency syndrome (AIDS).

Subsys

The Company's Subsys is a single-use product that delivers fentanyl, an opioid analgesic, in seconds for transmucosal absorption underneath the tongue. Subsys is a transmucosal product to show pain relief when measuring the sum of pain intensity difference at five minutes in a Phase 3 breakthrough cancer pain (BTCP) clinical trial using fentanyl.

Dronabinol Product Family

The Company has an approved dronabinol product and is developing several dronabinol product candidates for the treatment of CINV and appetite stimulation in patients with AIDS, as well as other indications where dronabinol could have potential therapeutic benefits. Dronabinol, the active ingredient in Marinol, is a synthetic cannabinoid whose chemical name is delta-9-tetrahydrocannabinol (THC). Its portfolio consists of its Dronabinol SG Capsule product and Dronabinol RT Capsule product candidate, which are intended to be generic equi! valents to Marinol, in addition to three formulations, including Dronabinol Oral Solution. Dronabinol SG Capsule is a dronabinol soft gelatin capsule intended to be a generic equivalent to Marinol. Dronabinol RT Capsule is a dronabinol soft gel capsule that is stable at room temperature. Dronabinol Oral Solution is a ynthetic THC in an oral liquid formulation.

Cancer Therapeutics

In addition to its cancer-supportive care products, the Company intends to develop cancer therapeutics targeting limitations of existing commercial products. LEP-ETU, it advanced cancer therapeutic, is a NeoLipid liposomal, or microscopic membrane-like structure created from lipids, formulation that incorporates paclitaxel. LEP-ETU completed a Phase 2 clinical trial of 70 patients with metastatic breast cancer.

The Company competes with Cephalon, Inc., BioDelivery Sciences International, Inc., ProStrakan Group plc, Nycomed International Management GmbH, Archimedes Pharma Ltd., TEVA Pharmaceuticals USA, Watson Pharmaceuticals, Inc., AcelRx Pharmaceuticals, Inc., Akela Pharma Inc., Abbott Laboratories, Pharmaceutical International, Inc., Par Pharmaceutical Companies Inc., sanofi-aventis, Eisai Inc., Helsinn Group, Roche Holding AG, Par Pharmaceutical Companies Inc., GlaxoSmithKline plc, ProStrakan Group plc, Merck & Co, GW Pharmaceutical, A.P. Pharma, Inc., Aphios Corp., Roche Holding, Tesaro, Inc., Cornerstone Pharmaceutical, Inc., Bristol-Myers Squibb, Celgene Corporation, Laboratories, Amgen Inc., AstraZeneca PLC., Bayer AG, Biogen Idec Inc., Eisai Co., Ltd., F. Hoffmann- LaRoche Ltd., Johnson and Johnson, Merck and Co., Inc., Novartis AG, Onyx Pharmaceuticals Inc., Pfizer Inc., and Takeda Pharmaceutical Co. Ltd.

Advisors' Opinion:
  • [By Traders Reserve]

    For example at the end of August, I found a little stock called INSYS Therapeutics (INSY) The company showed up as a top-rated stock using a stock-rating system based on something I call the P/E Gap ��the difference between a stock�� P/E ratio and its expected profit growth rate.

  • [By Jake L'Ecuyer]

    Equities Trading DOWN
    Shares of INSYS Therapeutics (NASDAQ: INSY) were down 15.94 percent to $38.00 after the company received subpoena from Office of Inspector General.

  • [By Jake L'Ecuyer]

    INSYS Therapeutics (NASDAQ: INSY) was also down, falling 15.14 percent to $27.73 after news broke that a doctor had fraudulently prescribed its drug Subsys.

10 Best Sliver Stocks To Own For 2014: Baxter International Inc. (BAX)

Baxter International Inc., through its subsidiaries, develops, manufactures, and markets products for people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. It operates in three segments: BioScience, Medication Delivery, and Renal. The BioScience segment processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products; and vaccines. The Medication Delivery segment manufactures intravenous solutions and administration sets; premixed drugs and drug-reconstitution systems; pre-filled vials and syringes for injectable drugs; intravenous nutrition products; infusion pumps; and inhalation anesthetics. It also offers products and services related to pha rmacy compounding, drug formulation, and packaging technologies. The Renal segment provides products to treat end-stage renal disease or irreversible kidney failure. It manufactures solutions and other products for peritoneal dialysis, a home-based therapy; and distributes product for hemodialysis, which is conducted in a hospital or clinic. It markets its products to hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors? offices, clinical and medical research laboratories, and patients at home under physician supervision. The company was founded in 1931 and is based in Deerfield, Illinois.

Advisors' Opinion:
  • [By Monica Gerson]

    Baxter International (NYSE: BAX) is expected to report its Q3 earnings at $1.19 per share on revenue of $3.81 billion.

    Dover (NYSE: DOV) is projected to report its Q3 earnings at $1.50 per share on revenue of $2.31 billion.

10 Best Sliver Stocks To Own For 2014: Enel SpA (ENEL)

Enel SpA is an Italy-based company engaged in the utilities sectors. It operates in seven divisions. The Sales segment focuses on the sale of electricity and gas products and services for end users. The Generation and Energy Management is involved in generation with thermal, natural gas regasification and schedulable hydroelectric power plants. The Infrastructure and Networks distributes electricity and public lighting. The Iberia and Latin America operates in the electricity and gas markets of Spain, Portugal and Latin America. The International segment supports strategies for the European and Russian markets. The Renewable Energy is active in the generation of electricity from renewable resources. The Engineering and Research develops the conventional and nuclear construction of power plants. In November 2013, through Enel Investment Holding BV, it sold a 40% stake in Artic Russia BV, which in turn owns a 49% of the share capital of SeverEnergia, to NK Rosneft' OAO. Advisors' Opinion:
  • [By Jonathan Morgan]

    Enel SpA (ENEL) retreated 3.8 percent to 3.22 euros after Deutsche Bank AG said that its estimates for earnings at Italy�� biggest utility show no potential for growth for 2013 or 2014.

No comments:

Post a Comment